Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes [NA]
A completed clinical trial assessing coordinated healthcare interventions to improve outcomes in childhood asthma; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Steroids In Eosinophil Negative Asthma [Phase 3]
Phase 3 clinical trial update for steroids in eosinophil-negative asthma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate Asthma [Phase 4]
Clinical trial update reporting dose response of fractional exhaled nitric oxide to inhaled steroids in mild-to-moderate asthma (Phase 4).
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Beta Blockers for the Treatment of Asthma [Phase 2]
Phase 2 clinical trial update evaluating beta blockers for the treatment of asthma has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma [Phase 4]
Phase 4 trial assessing additive effects of QVAR to Seretide on surrogate markers of airway inflammation in refractory asthma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Ultra-long Acting Bronchodilator Therapy in Asthmatics [Phase 4]
Phase 4 trial update on ultra-long acting bronchodilator therapy for asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Reversal of Acute β-Blocker Induced Bronchoconstriction [Phase 4]
Phase 4 clinical trial update reporting reversal of acute beta-blocker induced bronchoconstriction in asthma.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers [Phase 4]
Phase 4 trial evaluating lung bioavailability of HFA-Seretide using current spacer devices in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Effects of Particle Size in Small Airways Dysfunction [Phase 4]
Phase 4 clinical trial update examining how particle size affects small airways dysfunction in asthma.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol [Phase 4]
Phase 4 clinical trial evaluating trough bronchoprotection from levosalbutamol and racemic salbutamol in asthma.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma [Phase 2]
Phase 2 trial assessing efficacy and safety of risankizumab (BI 655066/ABBV-066) in patients with severe persistent asthma completed with re…
-
CLINICAL_TRIALS research · 2019-04-09Clinical Trial Update: Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers [Phase 4]
A Phase 4 longitudinal cohort study in severe asthma participants evaluating biomarkers.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis [Phase 4]
Phase 4 trial evaluating intranasal fluticasone plus azelastine for airway inflammation in patients with asthma and allergic rhinitis; study…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE) [NA]
A completed clinical trial updating on asthma phenotypes and pharmacogenomic interactions by race-ethnicity (SAPPHIRE).
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. [Phase 2]
A Phase 2 trial evaluating pharmacodynamics, safety, tolerability, and pharmacokinetics of two orally inhaled indacaterol salts in adults wi…
-
CLINICAL_TRIALS withdrawal · 2019-03-25Clinical Trial Update: Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma [Phase 3]
Phase 3 trial comparing FF/UMEC/VI vs FP/SAL plus tiotropium in inadequately controlled asthma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma [Phase 3]
Phase 3 clinical trial evaluating doxophylline as a corticosteroid-sparing therapy for children with asthma.
-
FDA approval · 2019-03-15FDA Approved: ALBUTEROL — Original Application (Nivagen Pharmaceuticals Inc)
FDA approves the original ANDA for albuterol sulfate (albuterol) from Nivagen Pharmaceuticals Inc, making a generic albuterol product availa…
-
EMA approval · 2019-03-01New add-on treatment for patients with severe asthma
EMA announces a new add-on treatment for patients with severe asthma, indicating a fresh therapeutic option may be available in the European…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation [Phase 3]
Phase 3 trial comparing one versus two doses of dexamethasone for pediatric asthma exacerbation has completed and posted results.
-
FDA approval · 2019-02-25FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's Albuterol Sulfate HFA inhalation product, authorizing changes under the approved NDA/appr…
-
FDA approval · 2019-02-21FDA Approved: PREDNISONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prednisone from Mylan Pharmaceuticals, indicating approval of an existing generic product's …
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation [Phase 4]
Phase 4 clinical trial update evaluating nebulized magnesium sulfate for children with moderate to severe asthma exacerbations; results were…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Asthmatuner a Self-management App for Asthma: A Randomized Controlled Multicentre Trial [NA]
A randomized multicenter trial evaluated Asthmatuner, a self-management mobile app for asthma, and has completed its assessment of the inter…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma [Phase 2]
A Phase 2 single-dose study assessed the safety and efficacy of S-1226 (8%) in subjects with mild atopic asthma; the trial status is complet…